Autopsy report · NCT02261883
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Registered 1 year 9 months before it started.
- Ran for about 7 years 10 months before it stopped.
- 42 participants enrolled.
- Results were posted on the registry 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- United Therapeutics
- Sponsor type
- Industry
- Conditions
- Persistent Pulmonary Hypertension of the Newborn
- Interventions
- IV Remodulin; Placebo
- Participants
- 42
- Sites
- 14
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.